Bayer Aktiengesellschaft (ETR:BAYN)
50.02
+0.64 (1.30%)
Sep 25, 2026, 5:35 PM CET
Bayer Aktiengesellschaft Employees
Bayer Aktiengesellschaft had 87,830 employees as of June 30, 2026. The number of employees decreased by 1,726 or -1.93% compared to the same quarter last year.
Employees
87,830
Change
-1,726
Growth
-1.93%
Revenue / Employee
€516,623
Profits / Employee
€19,788
Market Cap
49.14B
Employees Chart
| Date | Employees | Change (1Y) | Growth (1Y) |
|---|---|---|---|
| Jun 30, 2026 | 87,830 | -1,726 | -1.93% |
| Mar 31, 2026 | 87,757 | -3,128 | -3.44% |
| Dec 31, 2025 | 87,280 | -4,584 | -4.99% |
| Sep 30, 2025 | 88,502 | -5,743 | -6.09% |
| Jun 30, 2025 | 89,556 | -7,011 | -7.26% |
| Mar 31, 2025 | 90,885 | -7,304 | -7.44% |
| Dec 31, 2024 | 91,864 | -5,067 | -5.23% |
| Sep 30, 2024 | 94,245 | -6,628 | -6.57% |
| Jun 30, 2024 | 96,567 | -5,481 | -5.37% |
| Mar 31, 2024 | 98,189 | -3,546 | -3.49% |
| Dec 31, 2023 | 96,931 | -991 | -1.01% |
| Sep 30, 2023 | 100,873 | -1,423 | -1.39% |
| Jun 30, 2023 | 102,048 | 134 | 0.13% |
| Mar 31, 2023 | 101,735 | 982 | 0.97% |
| Dec 31, 2022 | 97,922 | 1,972 | 2.06% |
| Sep 30, 2022 | 102,296 | 2,482 | 2.49% |
| Jun 30, 2022 | 101,914 | 2,475 | 2.49% |
| Mar 31, 2022 | 100,753 | 1,424 | 1.43% |
| Dec 31, 2021 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Sep 30, 2021 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Jun 30, 2021 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2021 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Sep 30, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Jun 30, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Sep 30, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Sep 30, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Jun 30, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Sep 30, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Jun 30, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Related Stocks
| Company Name | Employees |
|---|---|
| Fresenius SE & Co. KGaA | 178,486 |
| Fresenius Medical Care AG | 107,226 |
| Siemens Healthineers AG | 74,300 |
| Merck KGaA | 62,136 |
| Fielmann Group AG | 18,928 |
| Drägerwerk AG & Co. KGaA | 16,009 |
| Sartorius Aktiengesellschaft | 14,279 |
| Ottobock SE & Co. KGaA | 9,406 |
Bayer Aktiengesellschaft News
- 4 days ago - Bayer to sell cancer drug Stigvarga for up to $431M, WSJ reports - TheFly
- 6 days ago - Bayer Sells Cancer Drug to Gruenenthal for Up to $431 Million - WSJ
- 10 days ago - Robigo announces Series A funding led by Leaps by Bayer - TheFly
- 10 days ago - Robigo and Leaps by Bayer Announce Series A Financing to Advance Engineered Biologicals That Protect Yields and Reduce Costs - Business Wire
- 10 days ago - Bayer receives FDA approval for Kerendia for CKD with type 1 diabetes - TheFly
- 10 days ago - Bayer's KERENDIA® (finerenone) Receives FDA Approval as the First New Treatment in 30 Years for Adults with Chronic Kidney Disease (CKD) and Type 1 Diabetes - Business Wire
- 13 days ago - Bayer's Monsanto unit urges Missouri judge to approve $7.25 billion Roundup settlement - Reuters
- 16 days ago - Bayer faces pivotal test of $7.25 billion Roundup settlement in Missouri court - Reuters